Beric Henderson is an NHMRC Senior Research Fellow and internationally recognized group leader in the field of protein trafficking and cancer, with research programs focused on gaining a molecular understanding of colon and breast cancer. He is the Head of the Gene Expression Laboratory at the Westmead Institute for Cancer Research and is associated with the Department of Medicine, University of Sydney. He graduated in science with B.S. degree with honors (First Class) in biochemistry from the University of New South Wales, Australia, in 1984 and went on to complete a Ph.D. degree in medicine at the University of Sydney in 1990. He then obtained a postdoctoral training at the Swiss Institute for Experimental Cancer Research in Lausanne, Switzerland (1992–1994) and subsequently at the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge England (1995-1996). He established a research team at the Westmead Millennium Institute in 1997. Dr. Henderson has a long standing interest in cancer and in the changes to gene and protein regulation during tumor progression. His laboratory established new methodologies to study intracellular movement of proteins and was the first to discover nuclear-cytoplasmic trafficking of the key tumor suppressing proteins APC (colon cancer), BRCA1 (breast cancer), and BARD1 (breast cancer).
Biography Updated on 30 March 2010